BofA Securities maintained a buy rating on Glenmark Life with a target price of Rs 560. Sustainable growth drivers are in focus.
PRISM’s IPO filing mentions Zostel case, CCI investigation
In its UDRHP-I filing to Sebi, the company any ‘adverse’ outcome in legal proceedings involving Zostel may materially and adversely affect its business, reputation, prospects,